A Bioequivalence Study of Citrate Free Mirikizumab (LY3074828) in Healthy Participants
Clinical trial NCT06475729 · COMPLETED
Trial details
- NCT number
- NCT06475729
- Sponsor
- Eli Lilly and Company
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-24
- Primary completion
- 2024-12-27
- Enrollment
- 498
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.